AstraZeneca and Daiichi Sankyo have welcomed the confirmation that the PBS listing of ENHERTU (trastuzumab deruxtecan) will be expanded on 1 September to include more women with a form of metastatic breast cancer. …
'We will continue to advocate for earlier, faster, fairer access to medicines for the benefit of all Australians'
August 29, 2024 Latest NewsBioPharma
Latest Video
New Stories
-
Todd Stephenson confirmed on ACT list for New Zealand election
September 14, 2026 - - Latest News -
Scandal-hit KPMG still holds $37 million in health department work
September 14, 2026 - - Latest News -
Canberra details tax changes with limited concessions for some innovators
September 14, 2026 - - Latest News -
The 'Dispatched' Week in Review Podcast - 11 September
September 11, 2026 - - Podcast -
Rare genetic motor neurone disease treatment finally reaches Australian patients
September 11, 2026 - - Latest News -
NSW pharmacists to deliver all childhood vaccines and treat more conditions under reforms
September 11, 2026 - - Latest News -
AI Health Summit 2026
September 10, 2026 - - Summit